The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP
Open accessAbstract
Cyclic-di-GMP and cyclic-di-AMP are second messengers produced by bacteria and influence bacterial cell survival, differentiation, colonization, biofilm formation, virulence, and bacteria–host interactions. In this study, we show that in both RAW264.7 macrophage cells and primary bone marrow-derived macrophages, the production of IFN-β and IL-6, but not TNF, in response to cyclic-di-AMP and cyclic-di-GMP requires MPYS (also known as STING, MITA, and TMEM173). Furthermore, expression of MPYS was required for IFN response factor 3 but not NF-κB activation in response to these bacterial metabolites. We also confirm that MPYS is required for type I IFN production by cultured macrophages infected with the intracellular pathogens Listeria monocytogenes and Francisella tularensis. However, during systemic infection with either pathogen, MPYS deficiency did not impact bacterial burdens in infected spleens. Serum IFN-β and IL-6 concentrations in the infected control and MPYS−/− mice were also similar at 24 h postinfection, suggesting that these pathogens stimulate MPYS-independent cytokine production during in vivo infection. Our findings indicate that bifurcating MPYS-dependent and -independent pathways mediate sensing of cytosolic bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759 · cited 3×
“Barber’s group (33, 42) showing that, in vivo, MPYS was required only for early (6 hpi) but not late (12 hpi) IFN-a and -b production in response to vesicular stomatitis virus infection.”
BackgroundIFI16 is an innate immune sensor for intracellular DNA
Unterholzner, L., Keating, S. E., Baran, M., Horan, K. A., Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1932 · Cited by 1,643
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Rathinam, V. A. K., Jiang, Z., Waggoner, S. N., Sharma, S., Cole, L. E., Waggoner, L., Vanaja, S. K., Monks, B. G., Ganesan, S., Latz, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1864 · Cited by 1,331
TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection
Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A., & Pamer, E. G. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,175
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Sun, W., Li, Y., Chen, L., Chen, H., You, F., Zhou, X., Zhou, Y., Zhai, Z., Chen, D., & Jiang, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900850106 · Cited by 866
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Woodward, J. J., Iavarone, A. T., & Portnoy, D. A. (2010) · Science · doi:10.1126/science.1189801 · Cited by 810
The AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1859 · Cited by 732
C‐di‐GMP: the dawning of a novel bacterial signalling system
Römling, U., Gomelsky, M., & Galperin, M. Y. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04697.x · Cited by 685
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
Sauer, J.-D., Sotelo-Troha, K., von Moltke, J., Monroe, K. M., Rae, C. S., Brubaker, S. W., Hyodo, M., Hayakawa, Y., Woodward, J. J., Portnoy, D. A., et al. (2011) · Infection and Immunity · doi:10.1128/iai.00999-10 · Cited by 539
The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to Intracellular Double-Stranded DNA
Tsuchida, T., Zou, J., Saitoh, T., Kumar, H., Abe, T., Matsuura, Y., Kawai, T., & Akira, S. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.013 · Cited by 493
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O'Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489
Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis
Jones, J. W., Kayagaki, N., Broz, P., Henry, T., Newton, K., O'Rourke, K., Chan, S., Dong, J., Qu, Y., Roose-Girma, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003738107 · Cited by 488
Roles of Cyclic Diguanylate in the Regulation of Bacterial Pathogenesis
Tamayo, R., Pratt, J. T., & Camilli, A. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093426 · Cited by 486
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M., & Portnoy, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040976 · Cited by 450
Jin, L., Waterman, P. M., Jonscher, K. R., Short, C. M., Reisdorph, N. A., & Cambier, J. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00640-08 · Cited by 450
Self-citationStanley, S. A., Johndrow, J. E., Manzanillo, P., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 432
Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
Carrero, J. A., Calderon, B., & Unanue, E. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040769 · Cited by 390
Sauer, J.-D., Witte, C. E., Zemansky, J., Hanson, B., Lauer, P., & Portnoy, D. A. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.04.004 · Cited by 321
Critical functions of priming and lysosomal damage for NLRP3 activation
Hornung, V., & Latz, E. (2010) · European Journal of Immunology · doi:10.1002/eji.200940185 · Cited by 297
McWhirter, S. M., Barbalat, R., Monroe, K. M., Fontana, M. F., Hyodo, M., Joncker, N. T., Ishii, K. J., Akira, S., Colonna, M., Chen, Z. J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082874 · Cited by 296
Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Wu, J., Fernandes-Alnemri, T., & Alnemri, E. S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9425-2 · Cited by 290
Innate recognition of bacteria by a macrophage cytosolic surveillance pathway
O'Riordan, M., Yi, C. H., Gonzales, R., Lee, K.-D., & Portnoy, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476699 · Cited by 282
Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome
Kim, S., Bauernfeind, F., Ablasser, A., Hartmann, G., Fitzgerald, K. A., Latz, E., & Hornung, V. (2010) · European Journal of Immunology · doi:10.1002/eji.201040425 · Cited by 255
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F., Gambuzza, M., Macrì, G., Ruggeri, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3126 · Cited by 251
Bacterial c-di-GMP Is an Immunostimulatory Molecule
Karaolis, D. K. R., Means, T. K., Yang, D., Takahashi, M., Yoshimura, T., Muraille, E., Philpott, D., Schroeder, J. T., Hyodo, M., Hayakawa, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2171 · Cited by 222
Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ
Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K., & Lenz, L. L. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091746 · Cited by 208
Self-citationType I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections
Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J.-D., Iwakura, Y., Metzger, D. W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902065 · Cited by 162
Cutting Edge: Cytosolic Bacterial DNA Activates the Inflammasome via Aim2
Warren, S. E., Armstrong, A. M., Hamilton, M. K., Mao, D. P., Leaf, I. A., Miao, E. A., & Aderem, A. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000724 · Cited by 159
Coers, J., Vance, R. E., Fontana, M. F., & Dietrich, W. F. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00963.x · Cited by 148
Anti-cytokine therapeutics and infections
Dinarello, C. A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00196-8 · Cited by 148
Opitz, B., Vinzing, M., van Laak, V., Schmeck, B., Heine, G., Günther, S., Preißner, R., Slevogt, H., N’Guessan, P. D., Eitel, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604638200 · Cited by 142
Tsuchiya, K., Hara, H., Kawamura, I., Nomura, T., Yamamoto, T., Daim, S. J., Dewamitta, S. R., Shen, Y., Fang, R., & Mitsuyama, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001058 · Cited by 127
Freudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., STÜBIG, H., & Galanos, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1665 · Cited by 121
Characterization of the Interferon-Producing Cell in Mice Infected with Listeria monocytogenes
Stockinger, S., Kastner, R., Kernbauer, E., Pilz, A., Westermayer, S., Reutterer, B., Soulat, D., Stengl, G., Vogl, C., Frenz, T., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000355 · Cited by 108
Crimmins, G. T., Herskovits, A. A., Rehder, K., Sivick, K. E., Lauer, P., Dubensky, T. W., & Portnoy, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804170105 · Cited by 108
Karaolis, D. K. R., Cheng, K., Lipsky, M., Elnabawi, A., Catalano, J. G., Hyodo, M., Hayakawa, Y., & Raufman, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.093 · Cited by 104
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection
Ogunniyi, A. D., Paton, J. C., Kirby, A. C., McCullers, J. A., Cook, J., Hyodo, M., Hayakawa, Y., & Karaolis, D. K. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.099 · Cited by 80
Incidence and nature of infectious disease in patients treated with anti-TNF agents
Raychaudhuri, S. P., Nguyen, C. T., Raychaudhuri, S. K., & Gershwin, M. E. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.08.006 · Cited by 73
Rayamajhi, M., Humann, J., Kearney, S. J., Hill, K. K., & Lenz, L. L. (2010) · Virulence · doi:10.4161/viru.1.5.12787 · Cited by 69
Self-citationSolodova, E., Jabłońska, J., Weiß, S., & Lienenklaus, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018543 · Cited by 62
Humann, J., Bjordahl, R., Andreasen, K., & Lenz, L. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2407 · Cited by 50
Self-citationCellular Reactive Oxygen Species Inhibit MPYS Induction of IFNβ
Jin, L., Lenz, L. L., & Cambier, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015142 · Cited by 43
Self-citationDresing, P., Borkens, S., Kocur, M., Kropp, S., & Scheu, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015567 · Cited by 41
Cited by
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Glück, S., Guey, B., Gulen, M. F., Wolter, K., Kang, T.-W., Schmacke, N. A., Bridgeman, A., Rehwinkel, J., Zender, L., & Ablasser, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3586 · Cited by 1,196
Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids
Wu, J., & Chen, Z. J. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120156 · Cited by 1,183
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS
Yu, C.-H., Davidson, S., Harapas, C. R., Hilton, J. B., Mlodzianoski, M. J., Laohamonthonkul, P., Louis, C., Low, R. R. J., Moecking, J., De Nardo, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.020 · Cited by 1,019
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
“, 1998), and STING / (Jin et al., 2011) strains have been described.”
Self-citationGoubau, D., Deddouche, S., & Reis e Sousa, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 843
Metadata
- Authors
- Jin, L., Hill, K. K., Filak, H., Mogan, J., Knowles, H., Zhang, B., Perraud, A.-L., Cambier, J. C., & Lenz, L. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-01
- Volume
- 187
- Issue
- 5
- Pages
- 2595-2601
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2161901483
- Cited by
- 288
- References
- 49
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.